Canadian Celiac Association offers up to $30,000 for celiac disease research

    NEXT STORY
    IN8bio announces first-in-human Phase 1 trial Update from The University of Kansas Cancer Center using INB-100, IN8bio’s Gamma Delta T-cell product candidate, at ASH 2020
    PREV STORY
    Add Kyolic Aged Garlic Extract for Better Heart Health
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Spero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer

    CAMBRIDGE, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset ...

    author_avatar
    NASDAQ Market News

    Agios to Webcast Conference Call of Third Quarter 2019 Financial Results on October 31, 2019

    author_avatar
    NASDAQ Market News

    Basilea presents preclinical data on its anticancer drug candidate BAL101553 at EORTC-NCI-AACR symposium

    Late-breaking abstracts on increased cure rates and synergistic effects of combinations with eribulin and ...

    author_avatar
    NASDAQ Market News